CONSOLIDATED BALANCE SHEETS (USD $)	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
CURRENT ASSETS
Cash	$ 1,250,279	$ 125,274	$ 143,907
Accounts receivable	95,177	208,781
Deferred financing costs	83,191	863
Prepaid expenses	50,699	29,602
TOTAL CURRENT ASSETS	1,479,346	364,520
Property and equipment, net	84,279	145
Patents, net	112,489	121,653
Deposits	18,988	10,376
TOTAL NON-CURRENT ASSETS	215,756	132,174
TOTAL ASSETS	1,695,102	496,694
CURRENT LIABILITIES
Accounts payable	517,651	822,832
Due to related parties	839,070	736,070
Notes payable	390,000	321,381
Convertible notes payable, current portion	1,367,655	2,367,631
Derivative liabilities	10,679,067	3,588,239
Other current liabilities	1,855,374	1,804,985
TOTAL CURRENT LIABILITIES	15,648,817	9,641,138
NONCURRENT LIABILITIES
Convertible notes payable, noncurrent portion	776,451	0
TOTAL NONCURRENT LIABILITIES	776,451	0
TOTAL LIABILITIES	16,425,268	9,641,138
COMMITMENTS AND CONTINGENCIES (Note 13)
STOCKHOLDERS' DEFICIT
Common stock, $0.001 par value, 500,000,000 and 250,000,000 shares authorized at March 31, 2014 and 2013, respectively; 224,973,980 and 173,674,201 issued and outstanding at March 31, 2014 and 2013, respectively	224,984	173,685
Additional paid-in capital	59,659,137	52,157,196
Accumulated deficit	(74,832,557)	(61,475,325)
TOTAL AETHLON MEDICAL, INC STOCKHOLDERS' DEFICIT	(14,948,436)	(9,144,444)	(9,295,621)
NONCONTROLLING INTERESTS	218,270	0
TOTAL DEFICIT	(14,730,166)	(9,144,444)
TOTAL LIABILITIES AND DEFICIT	1,695,102	496,694
Pro Forma [Member]
CURRENT ASSETS
Cash	1,250,279
Accounts receivable	95,177
Deferred financing costs	83,191
Prepaid expenses	50,699
TOTAL CURRENT ASSETS	1,479,346
Property and equipment, net	84,279
Patents, net	112,489
Deposits	18,988
TOTAL NON-CURRENT ASSETS	215,756
TOTAL ASSETS	1,695,102
CURRENT LIABILITIES
Accounts payable	517,651
Due to related parties	839,070
Notes payable	390,000
Convertible notes payable, current portion	482,655
Derivative liabilities	0
Other current liabilities	1,280,124
TOTAL CURRENT LIABILITIES	3,509,500
NONCURRENT LIABILITIES
Convertible notes payable, noncurrent portion	1,001,451
TOTAL NONCURRENT LIABILITIES	1,001,451
TOTAL LIABILITIES	4,510,951
COMMITMENTS AND CONTINGENCIES (Note 13)
STOCKHOLDERS' DEFICIT
Common stock, $0.001 par value, 500,000,000 and 250,000,000 shares authorized at March 31, 2014 and 2013, respectively; 224,973,980 and 173,674,201 issued and outstanding at March 31, 2014 and 2013, respectively	250,994
Additional paid-in capital	74,116,754
Accumulated deficit	(77,401,867)
TOTAL AETHLON MEDICAL, INC STOCKHOLDERS' DEFICIT	(3,034,119)
NONCONTROLLING INTERESTS	218,270
TOTAL DEFICIT	(2,815,849)
TOTAL LIABILITIES AND DEFICIT	$ 1,695,102